1 |
Baiocchi G, Guimaraes GC, Rosa Oliveira RA, et al (2012). Prognostic factors in pelvic exenteration for gynecological malignancies. Eur J SurgOncol, 38, 948-54.
|
2 |
Berek JS, Howe C, Lagasse LD, et al (2005). Pelvic exenteration for recurrent gynecologic malignancy: survival and morbidity analysis of the 45-year experience at UCLA. Gynecol Oncol, 99, 1539.
|
3 |
Brophy PF, Hoffman JP, Eisenberg BL (1994). The role of palliative pelvic exenteration. Am J Surg, 167, 386-90.
DOI
ScienceOn
|
4 |
Brunschwig A (1948). Complete excision of pelvic viscera for advanced carcinoma. Cancer, 1, 177-83.
DOI
|
5 |
Crowe PJ, Temple WJ, Lopez MJ, et al (1999). Pelvic exenteration for advanced pelvic malignancy. Semm Surg Oncol, 17, 152-60.
DOI
|
6 |
Decker PJ, Olsson C, Willaims LA, et al (1976). Pelvic exenteration as palliation of malignant disease. Am J Surg, 131, 509-15.
DOI
ScienceOn
|
7 |
Diver EJ, Rauh-Hain JA, Del Carmen MG (2012). Total Pelvic Exenteration for Gynecologic Malignancies. Int J Surg Oncol, 2012, 693535.
|
8 |
Eisenkop SM, Nalick RW, Teng NM (1991). Modified posterior exenteration for ovarian cancer. Obstet Gynecol,78, 879-85.
|
9 |
Eisenkop SM, Spirtos NM (2001). Procedures required to accomplish complete cytoreduction of ovarian cancer. Is there a correlation with biologic aggressiveness and survival? Gynecol Oncol, 82, 643-1.
|
10 |
Guimaraes GC, Baiocchi G, Ferreira FO, et al (2011). Palliative pelvic exenteration for patients with gynecologic malignancies. Arch Gynecol Obstet, 283, 1107-12.
DOI
|
11 |
Hockel M, Dornhofer N (2006). Pelvic exenteration for gynaecological tumors: achievements and unanswered questions. Lancet Oncol, 7, 837-47.
DOI
ScienceOn
|
12 |
Houvenaeghel G, Moutardier V, Karsenty G, et al (2004). Major complications of urinary diversion after pelvic exenteration for gynecologic malignancies; a 23-year mono-institutional experience in 124 patients. Gynecol Oncol, 92, 680-3.
DOI
ScienceOn
|
13 |
Kraybill WG, Lopez MJ, Bricker EM (1988). Total pelvic exenteration as a therapeutic option in advanced malignant disease of pelvis. Surg Gynecol Obstet, 166, 259-63.
|
14 |
Kuhrt MP, Chokshi RJ, Arrese D, et al (2012). Retrospective review of pelvic malignancies undergoing total pelvic exenteration. World J Surg Oncol, 10, 110.
DOI
|
15 |
Landoni F, Maneo A, Colombo A, et al (1997). Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet, 350, 535-40.
DOI
ScienceOn
|
16 |
Lawhead RA, Clark DGC, Smith DH, et al (1989). Pelvic exenteration for recurrent or persistent gynaecologic malignancies: a 10-year review of the memorial-sloankettering cancer center experience. Gynecol Oncol, 33, 279-82.
DOI
ScienceOn
|
17 |
Lichtinger M, Averette H, Penalver M, et al (1986). Major surgical procedures for gynecologic malignancy in elderly women. South Med J, 79, 1506-10.
DOI
|
18 |
Lopez MJ (1993). Pelvic exenteration. In: Cady B, Daly J (eds). Atlas of surgical Oncology. Mosby-Year Book, Chicago, 555.
|
19 |
Lopez MJ, Kraybill NJ, Downey RS, et al (1987). Exenterative surgery for locally advanced rectosigmoid cancers. Is it worth while? Surgery, 102, 644-51.
|
20 |
Lopez MJ, Monato WW (1993). Role of extended resection in the initial treatment of locally advanced colorectal carcinoma. Surgery, 113, 365-72.
|
21 |
Magrina JF (1990). Types of pelvic exenteration: a reappraisl. Gyneco Oncol, 37, 363-6.
DOI
ScienceOn
|
22 |
Matthews CM, Morris M, Burke TW, et al (1992). Pelvic exenteration in elderly patients. Obstet Gynecol, 79, 773-7.
|
23 |
Morley EW, Hopkins MP, Lindenauer SM, et al (1989). Pelvic exenteration, university of Michigan: 100 patients at 5 years. Obstet Gynecol, 74, 934-43.
|
24 |
Orr JW Jr, Shingleton HM, Hatch KD, et al (1983). Gastrointestinal complications associated with pelvic exenteration. Am J Obstet Gynecol, 145, 325-32.
|
25 |
Park JY, Choi HJ, Jeong SY, et al (2007). The role of pelvic exenteration and reconstructive treatment of advanced or recurrent gynecologic malignancies: Analysis of risk factors predicting recurrence and survival. J Surg Oncol, 96, 560-8.
DOI
ScienceOn
|
26 |
Powlik TM, Skibbes JM, Rodriguez Bigaz MA (2006). Educational review, Pelvic exenteration for advanced pelvic malignancies. Annuals Surgical Oncology, 13, 612-23
DOI
ScienceOn
|
27 |
Roberts WS, Cavanagh D, Bryson SC, et al (1987). Major morbidity after pelvic exenteration: a seven-year experience. Obstet Gynecol, 69, 617-21.
|
28 |
Sasson AR, Singurdson ER (2000). Management of locally advanced rectal cancer. Dis colon rectum, 43, 1695-701.
DOI
ScienceOn
|
29 |
Sharma S, Odunsi K, Discoll D, et al (2005). Pelvic exenteration for gynecological malignancies: twenty year experience at Rosewell Park Cancer Institute. Int J Gynecol Cancer, 15, 475-482.
DOI
ScienceOn
|
30 |
Schmidt AM, Imesch P, Fink D, Egger H (2012). Indications and long-term clinical outcomes in 282 patients with pelvic exenteration for advanced or recurrent cervical cancer. Gynecol Oncol, 125, 604-9.
DOI
ScienceOn
|
31 |
Soper JT, Berchuck A, Creasman WT, et al (1989). Pelvic exenteration: factors associated with major surgical morbidity. Gynecol Oncol, 35, 93-8.
DOI
ScienceOn
|
32 |
Talledo OE (1985). Pelvic exenteration-Medical College of Georgia experience. Gynecol Oncol, 22, 181-8.
DOI
ScienceOn
|
33 |
Tarrazo HM, Ellerkmann RM (1998). Pelvic radical surgery. Surg Oncol Clin North Am, 7, 399-416.
|
34 |
Zoucas E, Frederiksen S, Lydrup ML, et al (2010). Pelvic exenteration for advanced and recurrent malignancy. World J Surg, 34, 2177-84.
DOI
|